The utility of flourine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) for restaging of non-small cell lung cancer (NSCLC): Analysis of management change and survival in 63 consecutive patients.

被引：0
|
作者：
Hicks, RJ [1 ]
Binns, D [1 ]
Kalff, V [1 ]
Ware, RE [1 ]
MacManus, MP [1 ]
Ball, DL [1 ]
Hogg, A [1 ]
Matthews, J [1 ]
机构：
[1] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
296
引用
收藏
页码：75P / 75P
页数：1
相关论文
共 50 条
  • [1] The utility of flourine-18 fluorodeoxyglucose (18F FDG) positron emissiontomography (PET) for primary staging of non-small cell lung cancer (NSCLC):: Analysis of management change and survival in 153 consecutive patients.
    Hicks, RJ
    Binns, DS
    Kalff, V
    Hogg, A
    Ware, RE
    MacManus, MP
    Ball, DL
    Sutter, ME
    Matthews, J
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 109P - 109P
  • [2] Positron emission tomography (PET-FDG) predicts survival in patients with non-small cell lung cancer
    Dunagan, DP
    Chin, R
    Case, DL
    McCain, TW
    Harkness, BA
    Oaks, TE
    Haponik, EF
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A715 - A715
  • [3] Mediastinal lymph node staging in patients with non-small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)
    Mendez, Miriam
    Maximiano, Constanza
    Huelves, Miriam
    Gaston, Bernard
    de Speville, Doger
    Ibeas, Patricia
    Ruiz-Valdepenas, Andrea
    Palka, Magda
    Diaz, Gema
    Gomez, David
    Provencio, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Utility of positron emission tomography (PET) in potentially resectable patients with non-small cell lung carcinoma (NSCLC)
    Wigfield, C
    Bobadilla, JL
    Perlman, S
    Pratt, T
    Edwards, NM
    Weigel, TL
    CHEST, 2004, 126 (04) : 741S - 742S
  • [5] Positron emission tomography (PET) and improved survival in non-small cell lung cancer (NSCLC) patients: The Will Rogers Phenomenon revisited
    Chee, K.
    Huynh, D. V.
    Brown, M.
    Gandara, D. R.
    Wun, T.
    Lara, P. N., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Positron Emission Tomography (PET) radiotracers in oncology - utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
    Miele, Evelina
    Spinelli, Gian Paolo
    Tomao, Federica
    Zullo, Angelo
    De Marinis, Filippo
    Pasciuti, Giulia
    Rossi, Luigi
    Zoratto, Federica
    Tomao, Silverio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [7] Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
    Evelina Miele
    Gian Paolo Spinelli
    Federica Tomao
    Angelo Zullo
    Filippo De Marinis
    Giulia Pasciuti
    Luigi Rossi
    Federica Zoratto
    Silverio Tomao
    Journal of Experimental & Clinical Cancer Research, 27
  • [8] Positron emission tomography (PET) of non-small cell lung cancer
    Haberkorn, U
    LUNG CANCER, 2001, 34 : S115 - S121
  • [9] Early [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic non-small cell lung cancer (NSCLC).
    Helissey, Carole
    Metivier, Denis
    Rousseau, Claire
    Gontier, Eric
    Vedrine, Lionel
    Ceccaldi, Bernard
    Ferrand, Francois-Regis
    Bonardel, Gerald
    Le Moulec, Sylvestre
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Positron emission tomography in the management of non-small cell lung cancer
    Vansteenkiste, JF
    Stroobants, SG
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : 269 - +
12345